Higelin et al. (2018) demonstrated that ALS-associated NEK1 mutations led to dysregulation of DDR machinery and increased cell death to motor neurons, suggesting possible novel therapeutic strategies to reduce DNA damage in neurodegenerative diseases such as ALS [107]. This evidence concerns the gene NEK1 and amyotrophic lateral sclerosis.